http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000202995300319&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=8e1609b174ce4e31116a60747a720701Biochemical Research MethodsSCI(E)0MEETING ABSTRACT8S119-S119
International audienceHepatocellular carcinoma (HCC) is the second leading cause of death in oncolog...
Hepatocellular carcinoma is one of the most deadly liver malignancies found worldwide, with hepatiti...
Hepatocellular carcinoma (HCC) is an aggressive liver cancer but clinically validated biomarkers tha...
HUPO 4th Annual World Congress, Munich, Germany, 28 August - 1 September 2005. In Molecular and Cell...
In this project, human hepatocellular carcinoma (HCC) tumor tissue samples and corresponding adjacen...
In this project, human hepatocellular carcinoma (HCC) tumor tissue samples and corresponding adjacen...
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death worldwide. Inter...
Despite of the advances in clinical imaging and applied research in proteomic biomarkers, liver canc...
Hepatocellular carcinoma (HCC) is the third most common cause of mortality due to malignancy next to...
Reliable and accurate biomarkers are urgently needed to overcome the shortcomings of the current met...
Hepatocellular carcinoma (HCC) is an aggressive liver cancer but clinically validated biomarkers tha...
International audienceHepatocellular carcinoma (HCC) is the second leading cause of death in oncolog...
International audienceHepatocellular carcinoma (HCC) is the second leading cause of death in oncolog...
International audienceHepatocellular carcinoma (HCC) is the second leading cause of death in oncolog...
International audienceHepatocellular carcinoma (HCC) is the second leading cause of death in oncolog...
International audienceHepatocellular carcinoma (HCC) is the second leading cause of death in oncolog...
Hepatocellular carcinoma is one of the most deadly liver malignancies found worldwide, with hepatiti...
Hepatocellular carcinoma (HCC) is an aggressive liver cancer but clinically validated biomarkers tha...
HUPO 4th Annual World Congress, Munich, Germany, 28 August - 1 September 2005. In Molecular and Cell...
In this project, human hepatocellular carcinoma (HCC) tumor tissue samples and corresponding adjacen...
In this project, human hepatocellular carcinoma (HCC) tumor tissue samples and corresponding adjacen...
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death worldwide. Inter...
Despite of the advances in clinical imaging and applied research in proteomic biomarkers, liver canc...
Hepatocellular carcinoma (HCC) is the third most common cause of mortality due to malignancy next to...
Reliable and accurate biomarkers are urgently needed to overcome the shortcomings of the current met...
Hepatocellular carcinoma (HCC) is an aggressive liver cancer but clinically validated biomarkers tha...
International audienceHepatocellular carcinoma (HCC) is the second leading cause of death in oncolog...
International audienceHepatocellular carcinoma (HCC) is the second leading cause of death in oncolog...
International audienceHepatocellular carcinoma (HCC) is the second leading cause of death in oncolog...
International audienceHepatocellular carcinoma (HCC) is the second leading cause of death in oncolog...
International audienceHepatocellular carcinoma (HCC) is the second leading cause of death in oncolog...
Hepatocellular carcinoma is one of the most deadly liver malignancies found worldwide, with hepatiti...
Hepatocellular carcinoma (HCC) is an aggressive liver cancer but clinically validated biomarkers tha...